Gaudry, Stéphane http://orcid.org/0000-0002-1105-6785
Hajage, David
Martin-Lefevre, Laurent
Louis, Guillaume
Moschietto, Sébastien
Titeca-Beauport, Dimitri
La Combe, Béatrice
Pons, Bertrand
de Prost, Nicolas
Besset, Sébastien
Combes, Alain
Robine, Adrien
Beuzelin, Marion
Badie, Julio
Chevrel, Guillaume
Reignier, Jean
Bohé, Julien
Coupez, Elisabeth
Chudeau, Nicolas
Barbar, Saber
Vinsonneau, Christophe
Forel, Jean-Marie
Thevenin, Didier
Boulet, Eric
Lakhal, Karim
Aissaoui, Nadia
Grange, Steven
Leone, Marc
Lacave, Guillaume
Nseir, Saad
Poirson, Florent
Mayaux, Julien
Asehnoune, Karim
Geri, Guillaume
Klouche, Kada
Thiery, Guillaume
Argaud, Laurent
Ricard, Jean-Damien
Quenot, Jean-Pierre
Dreyfuss, Didier
Funding for this research was provided by:
Direction de l’hospitalisation et de l’offre de Soins (AOM16278)
Article History
Received: 31 July 2019
Accepted: 9 October 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: The study protocol and information forms were approved by the competent French legal authority (<i>Comité de Protection des Personnes Sud Est V, 7 February 2018</i>). The Comité de Protection des Personnes manage the central and the local aspects of the project.In the observational stage of the study, all patients are informed both verbally and with a written document by the principal investigator or a physician representing the investigator. Only an oral consent is required for this stage in accordance with French law.For all patients included in the randomized trial (randomization stage of the study), written informed consent is obtained by the principal investigator or a physician representing the investigator, before the person is enrolled on the study.
: The authors declare that they have no competing interests.